What does CUSIP 89422G107 represent in this 13F holders report?

CUSIP 89422G107 is the security identifier for TVTX - Travere Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held TVTX - Travere Therapeutics, Inc. - Common Stock in Q3 2022?

168 institutional investors reported TVTX - Travere Therapeutics, Inc. - Common Stock for Q3 2022. Use the holders table for investor-level position and value details.

Travere Therapeutics, Inc. - Common Stock (TVTX)

CUSIP: 89422G107

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Equity / Common Stock
Shares outstanding: 89,403,587
Total 13F shares: 69,779,173
Share change: -127,862
Total reported value: $1,719,469,986
Put/Call ratio: 29%
Price per share: $24.64
Number of holders: 168
Value change: -$2,015,044
Number of buys: 82
Number of sells: 79

Quarterly Holders Quick Answers

What is CUSIP 89422G107?
CUSIP 89422G107 identifies TVTX - Travere Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2022
Previous quarter: Q2 2022

Recent filing periods for CUSIP 89422G107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TVTX - Travere Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ARMISTICE CAPITAL, LLC	13F	Company	6%	5,320,000	$128,904,000	—	30 Jun 2022	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	5.5%	4,922,941	$119,283,000	—	30 Jun 2022	13F
BlackRock Finance, Inc.	13F	Company	5%	4,502,559	$109,096,000	—	30 Jun 2022	13F
JANUS HENDERSON GROUP PLC	13F	Company	4.5%	4,038,631	$97,871,000	—	30 Jun 2022	13F
MACQUARIE GROUP LTD	13F	Company	4.1%	3,668,679	$88,893,000	—	30 Jun 2022	13F
STATE STREET CORP	13F	Company	4%	3,607,165	$87,402,000	—	30 Jun 2022	13F
Deep Track Capital, LP	13F	Company	4%	3,580,700	$86,760,000	—	30 Jun 2022	13F
VANGUARD GROUP INC	13F	Company	3.7%	3,330,819	$80,707,000	—	30 Jun 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	3.7%	3,300,009	$79,959,000	—	30 Jun 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	2.9%	2,612,646	$63,305,000	—	30 Jun 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	2.2%	1,950,000	$47,249,000	—	30 Jun 2022	13F
VR Adviser, LLC	13F	Company	1.9%	1,711,102	$41,460,000	—	30 Jun 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.9%	1,657,022	$40,150,000	—	30 Jun 2022	13F
CITADEL ADVISORS LLC	13F	Company	1.5%	1,306,036	$31,645,000	—	30 Jun 2022	13F
Kynam Capital Management, LP	13F	Company	1.4%	1,235,151	$29,928,000	—	30 Jun 2022	13F
JPMORGAN CHASE & CO	13F	Company	1.2%	1,097,937	$26,602,000	—	30 Jun 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	1,024,925	$24,833,000	—	30 Jun 2022	13F
GREAT POINT PARTNERS LLC	13F	Company	1.1%	971,233	$23,533,000	—	30 Jun 2022	13F
Rock Springs Capital Management LP	13F	Company	1.1%	951,650	$23,058,000	—	30 Jun 2022	13F
Assenagon Asset Management S.A.	13F	Company	1.1%	950,465	$23,030,000	—	30 Jun 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.97%	864,060	$20,936,000	—	30 Jun 2022	13F
Laurion Capital Management LP	13F	Company	0.93%	834,961	$20,231,000	—	30 Jun 2022	13F
ORBIMED ADVISORS LLC	13F	Company	0.86%	772,200	$18,710,000	—	30 Jun 2022	13F
NORTHERN TRUST CORP	13F	Company	0.71%	636,514	$15,422,000	—	30 Jun 2022	13F
MORGAN STANLEY	13F	Company	0.66%	585,756	$14,192,000	—	30 Jun 2022	13F
Finepoint Capital LP	13F	Company	0.65%	584,300	$14,158,000	—	30 Jun 2022	13F
Polar Asset Management Partners Inc.	13F	Company	0.65%	582,700	$14,119,000	—	30 Jun 2022	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.64%	570,084	$13,813,000	—	30 Jun 2022	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.62%	557,903	$13,518,000	—	30 Jun 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.61%	545,234	$13,210,000	—	30 Jun 2022	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.61%	544,293	$13,188,219	—	30 Jun 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.59%	524,296	$12,704,000	—	30 Jun 2022	13F
Invesco Ltd.	13F	Company	0.56%	499,486	$12,103,000	—	30 Jun 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.53%	470,147	$11,392,000	—	30 Jun 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.49%	436,957	$10,776,000	—	30 Jun 2022	13F
FMR LLC	13F	Company	0.49%	438,803	$10,632,000	—	30 Jun 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.48%	428,827	$10,390,000	—	30 Jun 2022	13F
PICTET ASSET MANAGEMENT SA	13F	Company	0.39%	353,025	$8,554,000	—	30 Jun 2022	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	0.35%	310,500	$7,523,000	—	30 Jun 2022	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.34%	301,186	$7,298,000	—	30 Jun 2022	13F
MPM BioImpact LLC	13F	Company	0.31%	277,950	$6,735,000	—	30 Jun 2022	13F
Tekla Capital Management LLC	13F	Company	0.28%	247,678	$6,001,000	—	30 Jun 2022	13F
GW&K Investment Management, LLC	13F	Company	0.28%	246,526	$5,973,000	—	30 Jun 2022	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.27%	237,551	$5,756,000	—	30 Jun 2022	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.26%	232,000	$5,621,000	—	30 Jun 2022	13F
AXA S.A.	13F	Company	0.26%	230,090	$5,575,081	—	30 Jun 2022	13F
Sofinnova Investments, Inc.	13F	Company	0.24%	212,593	$5,151,000	—	30 Jun 2022	13F
Walleye Capital LLC	13F	Company	0.23%	207,895	$5,037,000	—	30 Jun 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.22%	200,333	$4,854,000	—	30 Jun 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.22%	192,816	$4,672,000	—	30 Jun 2022	13F

Institutional Holders of Travere Therapeutics, Inc. - Common Stock (TVTX) as of Q3 2022

As of 30 Sep 2022, Travere Therapeutics, Inc. - Common Stock (TVTX) was held by 168 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 69,779,173 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., Deep Track Capital, LP, JANUS HENDERSON GROUP PLC, STATE STREET CORP, VANGUARD GROUP INC, MACQUARIE GROUP LTD, BAKER BROS. ADVISORS LP, and GOLDMAN SACHS GROUP INC. This page lists 168 institutional shareholders reporting positions in this security for the Q3 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

166

Q3 2022 holders

168

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 Value $	Q3 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.